Logo image of VHI.CA

VITALHUB CORP (VHI.CA) Stock Fundamental Analysis

TSX:VHI - Toronto Stock Exchange - CA92847V5018 - Common Stock - Currency: CAD

11.7  +0.3 (+2.63%)

Fundamental Rating

6

Taking everything into account, VHI scores 6 out of 10 in our fundamental rating. VHI was compared to 8 industry peers in the Health Care Technology industry. VHI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. VHI is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make VHI a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year VHI was profitable.
VHI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VHI reported negative net income in multiple years.
VHI had a positive operating cash flow in 4 of the past 5 years.
VHI.CA Yearly Net Income VS EBIT VS OCF VS FCFVHI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

1.2 Ratios

With an excellent Return On Assets value of 1.45%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
VHI's Return On Equity of 2.07% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
The Return On Invested Capital of VHI (3.93%) is better than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VHI is in line with the industry average of 3.93%.
Industry RankSector Rank
ROA 1.45%
ROE 2.07%
ROIC 3.93%
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
VHI.CA Yearly ROA, ROE, ROICVHI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

With an excellent Profit Margin value of 4.37%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
VHI has a better Operating Margin (13.68%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of VHI has grown nicely.
VHI has a Gross Margin of 80.90%. This is amongst the best in the industry. VHI outperforms 87.50% of its industry peers.
In the last couple of years the Gross Margin of VHI has grown nicely.
Industry RankSector Rank
OM 13.68%
PM (TTM) 4.37%
GM 80.9%
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
VHI.CA Yearly Profit, Operating, Gross MarginsVHI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VHI is destroying value.
The number of shares outstanding for VHI has been increased compared to 1 year ago.
Compared to 5 years ago, VHI has more shares outstanding
The debt/assets ratio for VHI has been reduced compared to a year ago.
VHI.CA Yearly Shares OutstandingVHI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
VHI.CA Yearly Total Debt VS Total AssetsVHI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

VHI has an Altman-Z score of 6.82. This indicates that VHI is financially healthy and has little risk of bankruptcy at the moment.
VHI has a better Altman-Z score (6.82) than 87.50% of its industry peers.
VHI has a debt to FCF ratio of 0.04. This is a very positive value and a sign of high solvency as it would only need 0.04 years to pay back of all of its debts.
VHI has a better Debt to FCF ratio (0.04) than 87.50% of its industry peers.
VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
VHI's Debt to Equity ratio of 0.00 is amongst the best of the industry. VHI outperforms 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Altman-Z 6.82
ROIC/WACC0.42
WACC9.34%
VHI.CA Yearly LT Debt VS Equity VS FCFVHI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.70 indicates that VHI should not have too much problems paying its short term obligations.
VHI has a Current ratio of 1.70. This is in the better half of the industry: VHI outperforms 62.50% of its industry peers.
A Quick Ratio of 1.69 indicates that VHI should not have too much problems paying its short term obligations.
VHI's Quick ratio of 1.69 is fine compared to the rest of the industry. VHI outperforms 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.69
VHI.CA Yearly Current Assets VS Current LiabilitesVHI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

VHI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.36%.
The Revenue has grown by 30.64% in the past year. This is a very strong growth!
The Revenue has been growing by 46.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-36.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)30.64%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%51.37%

3.2 Future

Based on estimates for the next years, VHI will show a very strong growth in Earnings Per Share. The EPS will grow by 82.32% on average per year.
The Revenue is expected to grow by 26.69% on average over the next years. This is a very strong growth
EPS Next Y215.37%
EPS Next 2Y107.06%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue Next Year30.64%
Revenue Next 2Y19.52%
Revenue Next 3Y26.69%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
VHI.CA Yearly Revenue VS EstimatesVHI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
VHI.CA Yearly EPS VS EstimatesVHI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4

6

4. Valuation

4.1 Price/Earnings Ratio

VHI is valuated quite expensively with a Price/Earnings ratio of 167.14.
VHI's Price/Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.22. VHI is valued rather expensively when compared to this.
VHI is valuated quite expensively with a Price/Forward Earnings ratio of 53.00.
VHI's Price/Forward Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 100.00% of the companies in the same industry.
VHI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.86.
Industry RankSector Rank
PE 167.14
Fwd PE 53
VHI.CA Price Earnings VS Forward Price EarningsVHI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VHI is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than VHI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 45.82
EV/EBITDA 37.79
VHI.CA Per share dataVHI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

VHI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VHI has a very decent profitability rating, which may justify a higher PE ratio.
VHI's earnings are expected to grow with 82.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.78
PEG (5Y)N/A
EPS Next 2Y107.06%
EPS Next 3Y82.32%

0

5. Dividend

5.1 Amount

VHI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VITALHUB CORP

TSX:VHI (5/2/2025, 7:00:00 PM)

11.7

+0.3 (+2.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-27 2025-03-27/amc
Earnings (Next)05-08 2025-05-08
Inst Owners30.84%
Inst Owner ChangeN/A
Ins Owners12.77%
Ins Owner ChangeN/A
Market Cap652.63M
Analysts81.67
Price Target14.09 (20.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.87%
Min EPS beat(2)-33.99%
Max EPS beat(2)-25.74%
EPS beat(4)0
Avg EPS beat(4)-53.99%
Min EPS beat(4)-130.46%
Max EPS beat(4)-25.74%
EPS beat(8)1
Avg EPS beat(8)-27.09%
EPS beat(12)2
Avg EPS beat(12)-30.49%
EPS beat(16)2
Avg EPS beat(16)-91.06%
Revenue beat(2)1
Avg Revenue beat(2)1.93%
Min Revenue beat(2)-0.84%
Max Revenue beat(2)4.69%
Revenue beat(4)3
Avg Revenue beat(4)3.33%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)5.76%
Revenue beat(8)6
Avg Revenue beat(8)3.33%
Revenue beat(12)9
Avg Revenue beat(12)3.85%
Revenue beat(16)11
Avg Revenue beat(16)2.87%
PT rev (1m)2.31%
PT rev (3m)3.97%
EPS NQ rev (1m)-7.16%
EPS NQ rev (3m)-3.71%
EPS NY rev (1m)-2.86%
EPS NY rev (3m)-0.65%
Revenue NQ rev (1m)3.82%
Revenue NQ rev (3m)4%
Revenue NY rev (1m)2.35%
Revenue NY rev (3m)2.25%
Valuation
Industry RankSector Rank
PE 167.14
Fwd PE 53
P/S 9.51
P/FCF 45.82
P/OCF 43.14
P/B 4.51
P/tB 39.81
EV/EBITDA 37.79
EPS(TTM)0.07
EY0.6%
EPS(NY)0.22
Fwd EY1.89%
FCF(TTM)0.26
FCFY2.18%
OCF(TTM)0.27
OCFY2.32%
SpS1.23
BVpS2.6
TBVpS0.29
PEG (NY)0.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.45%
ROE 2.07%
ROCE 5.76%
ROIC 3.93%
ROICexc 6.02%
ROICexgc N/A
OM 13.68%
PM (TTM) 4.37%
GM 80.9%
FCFM 20.76%
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score4
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Debt/EBITDA 0.02
Cap/Depr 14.82%
Cap/Sales 1.29%
Interest Coverage 250
Cash Conversion 98.57%
Profit Quality 474.99%
Current Ratio 1.7
Quick Ratio 1.69
Altman-Z 6.82
F-Score4
WACC9.34%
ROIC/WACC0.42
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y215.37%
EPS Next 2Y107.06%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue 1Y (TTM)30.64%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%51.37%
Revenue Next Year30.64%
Revenue Next 2Y19.52%
Revenue Next 3Y26.69%
Revenue Next 5YN/A
EBIT growth 1Y52.67%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year65.66%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-29.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-26.11%
OCF growth 3YN/A
OCF growth 5YN/A